Document is current
Any future updates will be listed below
-
Authors
Williams, Leanne M. http://orcid.org/0000-0001-9987-7360
Coman, John T.
Stetz, Patrick C.
Walker, Nicole C.
Kozel, F. Andrew
George, Mark S.
Yoon, Jong
Hack, Laura M.
Madore, Michelle R.
Lim, Kelvin O.
Philip, Noah S.
Holtzheimer, Paul E.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01MH120126, R01MH120126)
National Institute of Mental Health (R01MH120126, R01MH120126, R01MH120126, R01MH120126)
- License Information
-
More Information
Article History
Received: 14 October 2020
Accepted: 22 December 2020
First Online: 13 January 2021
Ethics approval and consent to participate
: The ethics approval for this study was granted by the Stanford University Institutional Review Board (eProtocol #52695; Registration 351). Important modifications will be communicated to the IRB and partner study sites. Eligible and interested veterans will be provided with written copies of the consent forms prior to the commencement of their clinical TMS treatment. Participants will give written consent. Research team members will guide these potential participants through the consent information and provide them with the opportunity to ask questions.
: Not applicable.
: LMW, LMH, MRM, KOL, JHY, JTC, PCS and NCW have no competing interests. NSP served as an unpaid advisory board member for Microtransponder Neuronetics. FAK was an unpaid consultant for Microtransponder Neuronetics. MSG was a consultant for Puretech Ventures and unpaid consultant for Microtransponder Neuronetics, Mecta, Magstim and Brainsway. MSG served as a Journal Editor for Elsevier Press and as a Data Safety Monitoring Board member for Microtransponder Neuronetics. PEH is a consultant for Abbot and receives royalties from UpToDate and Oxford University Press.
